Phase II trial of panitumumab with irinotecan as salvage therapy for patients with advanced or recurrent colorectal cancer (TOPIC study)

Little is known about the clinical impact of salvage panitumumab with irinotecan for metastatic colorectal cancer (mCRC) patients. The present study conducted a single-arm, multicenter phase II trial for mCRC with skin toxicity prevention program. The subjects were mCRC patients with wild-type KRAS,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncol Lett
Prif Awduron: NISHI, TOMOHIRO, HAMAMOTO, YASUO, NAGASE, MICHITAKA, DENDA, TADAMICHI, YAMAGUCHI, KENSEI, AMAGAI, KENJI, MIYATA, YOSHINORI, YAMANAKA, YASUHIRO, YANAI, KAI, ISHIKAWA, TSUTOMU, KUROKI, YOSHIFUMI, FUJII, HIROFUMI
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2016
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888220/
https://ncbi.nlm.nih.gov/pubmed/27313739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4532
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg